HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,054 | +5.8% | 27,600 | 0.0% | 0.04% | +2.3% |
| Q2 2023 | $996 | +6.4% | 27,600 | +12.7% | 0.04% | -6.4% |
| Q1 2023 | $936 | -24.2% | 24,500 | +12.9% | 0.05% | -28.8% |
| Q4 2022 | $1,235 | -99.9% | 21,700 | 0.0% | 0.07% | +40.4% |
| Q3 2022 | $858,000 | -10.2% | 21,700 | 0.0% | 0.05% | +2.2% |
| Q2 2022 | $955,000 | -9.3% | 21,700 | -17.8% | 0.05% | +17.9% |
| Q1 2022 | $1,053,000 | -0.8% | 26,400 | 0.0% | 0.04% | +8.3% |
| Q4 2021 | $1,062,000 | -1.1% | 26,400 | 0.0% | 0.04% | -2.7% |
| Q3 2021 | $1,074,000 | -10.4% | 26,400 | 0.0% | 0.04% | -9.8% |
| Q2 2021 | $1,199,000 | +27.8% | 26,400 | +17.3% | 0.04% | +10.8% |
| Q1 2021 | $938,000 | -2.4% | 22,500 | 0.0% | 0.04% | -9.8% |
| Q4 2020 | $961,000 | – | 22,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |